Adaptive cells from AML patients also exhibited higher expression levels of CD56 and CD57, as compared to HDs, while levels of KIRs and DNAM-1 were significantly lower (Supplementary Figure S1E). The gene discussed is NCAM1; the disease is acute myeloid leukemia.